Ignite Creation Date:
2024-05-06 @ 7:56 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06195202
Status:
RECRUITING
Last Update Posted:
2024-01-09
First Post:
2023-12-24
Brief Title:
Serum Estradiol E2 Levels in Breast Cancer Patients During Endocrine Therapy by High Performance Liquid Chromatography-tandem Mass Spectrometry LC-MS MS
Sponsor:
Sun Yat-sen University
Organization:
Sun Yat-sen University
Study Overview
Official Title:
A Prospective Cohort Study of Serum Estradiol E2 Levels in Breast Cancer Patients During Endocrine Therapy by High Performance Liquid Chromatography-tandem Mass Spectrometry LC-MS MS
Status:
RECRUITING
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators intend to conduct a prospective cohort study to detect E2 levels during endocrine therapy in Chinese breast cancer patients using LC-MSMS methods and to determine the proportion of patients with premenopausal E2 levels OFR or E2 insufficiency during AIs or FUL endocrine therapy To further explore the correlation between serum E2 levels and the efficacy of endocrine therapy in Chinese patients so as to ensure the safety and efficacy of endocrine therapy for patients and pave the way for further providing more accurate individualized treatment programs
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None